Innovations in Immunohistochemistry

Diana Gina Poalelungi,Anca Iulia Neagu,Ana Fulga,Marius Neagu,Dana Tutunaru,Aurel Nechita,Iuliu Fulga

DOI: https://doi.org/10.3390/jpm14070693

IF: 3.5083

2024-06-27

Journal of Personalized Medicine

Abstract:Artificial intelligence (AI) is a reality of our times, and it has been successfully implemented in all fields, including medicine. As a relatively new domain, all efforts are directed towards creating algorithms applicable in most medical specialties. Pathology, as one of the most important areas of interest for precision medicine, has received significant attention in the development and implementation of AI algorithms. This focus is especially important for achieving accurate diagnoses. Moreover, immunohistochemistry (IHC) serves as a complementary diagnostic tool in pathology. It can be further augmented through the application of deep learning (DL) and machine learning (ML) algorithms for assessing and analyzing immunohistochemical markers. Such advancements can aid in delineating targeted therapeutic approaches and prognostic stratification. This article explores the applications and integration of various AI software programs and platforms used in immunohistochemical analysis. It concludes by highlighting the application of these technologies to pathologies such as breast, prostate, lung, melanocytic proliferations, and hematologic conditions. Additionally, it underscores the necessity for further innovative diagnostic algorithms to assist physicians in the diagnostic process.

medicine, general & internal,health care sciences & services

What problem does this paper attempt to address?

### Problems the Paper Aims to Address

This paper explores the application of artificial intelligence (AI) in pathology, particularly in the field of immunohistochemistry (IHC). Specifically, the paper aims to address the following issues:

1. **Improving Diagnostic Accuracy**:
- Utilizing AI algorithms for automated analysis of IHC stained images to enhance diagnostic accuracy and consistency.
- Evaluating and analyzing immunohistochemical markers through deep learning (DL) and machine learning (ML) algorithms to assist pathologists in making accurate diagnoses.

2. **Standardization and Reproducibility**:
- Standardizing the scoring process of IHC markers using AI technology to reduce subjective differences in manual scoring.
- Enhancing the reproducibility and reliability of IHC assessment results.

3. **Quantitative Analysis**:
- Employing AI technology for quantitative analysis to improve the precision and efficiency of the diagnostic process.
- Particularly in the diagnosis of diseases such as breast cancer, prostate cancer, and lung cancer, AI technology can significantly improve the detection accuracy of important markers like Ki67 and HER2.

4. **Integration of AI Software with Digital Pathology Systems**:
- Integrating AI software into digital pathology systems to increase the automation level of pathology workflows.
- Automatically detecting and marking common artifacts in tissue section images, such as bubbles and out-of-focus areas.

5. **Application to Multiple Cancer Types**:
- Exploring the application of AI technology in various types of cancers, including but not limited to breast cancer, prostate cancer, lung cancer, malignant melanoma, and lymphoma.
- Analyzing the spatial relationships of specific immune cells to provide new avenues for research on tumor progression and treatment response.

In summary, this paper aims to revolutionize immunohistochemical analysis methods in pathology by introducing AI technology, thereby improving diagnostic accuracy and efficiency and supporting precision medicine.